Besides that several observational studies indicate safety and efficacy of tPA-treatment in stroke patients > 80 years [22–25] and the results of the third international stroke trial (IST-3) suggest that age should not be a barrier to IVT [26]. Here, PLAT is linked to stroke disorder.